PIM1 and melanoma: Incubation of melanoma cells with SGI‐1776 markedly and in a dose‐dependent manner reduced Gal‐1 protein abundance (Fig. 5D), indicating that PIM inhibition is a potential immunomodulatory strategy in this disease.